LN

Lakshmi Narasimha Rao Chandana

Active Director Director DIN 06574439
DIN 06574439 First appointment Apr 2013 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Lakshmi Narasimha Rao Chandana

Data last updated:

Lakshmi Narasimha Rao Chandana is a Director at Quali-Care Pharmaceuticals Limited (since 2013). The company operates in Pharma.

DIN 06574439
Primary Designation Director
Industry Pharma
First Appointment 20 Apr 2013
Oldest Company Age 40 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Quali-Care Pharmaceuticals Limited U24239TG1985PLC005955
Director20 Apr 20131985Active

Board colleagues of Lakshmi Narasimha Rao Chandana

Directorship timeline

Open interactive timeline →
Quali-Care Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Lakshmi Narasimha Rao Chandana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lakshmi Narasimha Rao Chandana

Lakshmi Narasimha Rao Chandana currently holds 1 directorship: Quali-Care Pharmaceuticals Limited (Director, since 20 Apr 2013).

Lakshmi Narasimha Rao Chandana was first appointed on 20 Apr 2013 as Director at Quali-Care Pharmaceuticals Limited.

The current boards of Lakshmi Narasimha Rao Chandana's companies include Anand Kumar Veerapaneni (Quali-Care Pharmaceuticals Limited), Surya Bhaskaramma Veerapaneni (Quali-Care Pharmaceuticals Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available